Global Pediatric Orphan Drugs Supply, Demand and Key Producers, 2023-2029

Description

The global Pediatric Orphan Drugs market size is expected to reach $ 103570 million by 2029, rising at a market growth of 10.0% CAGR during the forecast period (2023-2029).

According to our “ Pharma & Healthcare Research Center” statistics, the global sales of Orphan Drugs reached $139170 million in 2022. The North America region was the world largest Orphan Drugs market, accounting for 40% of Orphan Drugs sales in 2022,  followed by Asia-Pacific. The global market for pediatric orphan drugs has been growing steadily in recent years due to increasing awareness of rare pediatric diseases, advancements in medical research and technology, and improved regulatory support for pediatric drug development.

Pediatric orphan drugs are medications that are specifically developed and approved for the treatment of rare diseases or conditions in children. These drugs are designed to address medical needs in pediatric populations who have limited treatment options due to the rarity of their conditions. Pediatric orphan drugs are vital in addressing the unique medical needs of children with rare diseases and improving their health outcomes and quality of life.

This report studies the global Pediatric Orphan Drugs demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Pediatric Orphan Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pediatric Orphan Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Pediatric Orphan Drugs total market, 2018-2029, (USD Million)
Global Pediatric Orphan Drugs total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Pediatric Orphan Drugs total market, key domestic companies and share, (USD Million)
Global Pediatric Orphan Drugs revenue by player and market share 2018-2023, (USD Million)
Global Pediatric Orphan Drugs total market by Type, CAGR, 2018-2029, (USD Million)
Global Pediatric Orphan Drugs total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Pediatric Orphan Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Recordati SpA, Novartis, Celgene, Abbvie, Orpharma, Amgen, Amryt Pharma Plc., Johnson & Johnson and GSK, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pediatric Orphan Drugs market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Pediatric Orphan Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Pediatric Orphan Drugs Market, Segmentation by Type
    Oncology Drugs
    Gastrointestinal Drugs
    Neurology Drugs
    Cardio-vascular Drugs
    Others

Global Pediatric Orphan Drugs Market, Segmentation by Application
    Hospital Pharmacies
    Retail pharmacies
    Others

Companies Profiled:
    Recordati SpA
    Novartis
    Celgene
    Abbvie
    Orpharma
    Amgen
    Amryt Pharma Plc.
    Johnson & Johnson
    GSK
    Bristol-Myers Squibb Company
    Roche Holding
    Pfizer
    Sanofi
    Takeda

Key Questions Answered
1. How big is the global Pediatric Orphan Drugs market?
2. What is the demand of the global Pediatric Orphan Drugs market?
3. What is the year over year growth of the global Pediatric Orphan Drugs market?
4. What is the total value of the global Pediatric Orphan Drugs market?
5. Who are the major players in the global Pediatric Orphan Drugs market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Pediatric Orphan Drugs Introduction
    1.2 World Pediatric Orphan Drugs Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Pediatric Orphan Drugs Total Market by Region (by Headquarter Location)
        1.3.1 World Pediatric Orphan Drugs Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Pediatric Orphan Drugs Market Size (2018-2029)
        1.3.3 China Pediatric Orphan Drugs Market Size (2018-2029)
        1.3.4 Europe Pediatric Orphan Drugs Market Size (2018-2029)
        1.3.5 Japan Pediatric Orphan Drugs Market Size (2018-2029)
        1.3.6 South Korea Pediatric Orphan Drugs Market Size (2018-2029)
        1.3.7 ASEAN Pediatric Orphan Drugs Market Size (2018-2029)
        1.3.8 India Pediatric Orphan Drugs Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Pediatric Orphan Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Pediatric Orphan Drugs Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Pediatric Orphan Drugs Consumption Value (2018-2029)
    2.2 World Pediatric Orphan Drugs Consumption Value by Region
        2.2.1 World Pediatric Orphan Drugs Consumption Value by Region (2018-2023)
        2.2.2 World Pediatric Orphan Drugs Consumption Value Forecast by Region (2024-2029)
    2.3 United States Pediatric Orphan Drugs Consumption Value (2018-2029)
    2.4 China Pediatric Orphan Drugs Consumption Value (2018-2029)
    2.5 Europe Pediatric Orphan Drugs Consumption Value (2018-2029)
    2.6 Japan Pediatric Orphan Drugs Consumption Value (2018-2029)
    2.7 South Korea Pediatric Orphan Drugs Consumption Value (2018-2029)
    2.8 ASEAN Pediatric Orphan Drugs Consumption Value (2018-2029)
    2.9 India Pediatric Orphan Drugs Consumption Value (2018-2029)

3 World Pediatric Orphan Drugs Companies Competitive Analysis
    3.1 World Pediatric Orphan Drugs Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Pediatric Orphan Drugs Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Pediatric Orphan Drugs in 2022
        3.2.3 Global Concentration Ratios (CR8) for Pediatric Orphan Drugs in 2022
    3.3 Pediatric Orphan Drugs Company Evaluation Quadrant
    3.4 Pediatric Orphan Drugs Market: Overall Company Footprint Analysis
        3.4.1 Pediatric Orphan Drugs Market: Region Footprint
        3.4.2 Pediatric Orphan Drugs Market: Company Product Type Footprint
        3.4.3 Pediatric Orphan Drugs Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Pediatric Orphan Drugs Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Pediatric Orphan Drugs Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Pediatric Orphan Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Pediatric Orphan Drugs Consumption Value Comparison
        4.2.1 United States VS China: Pediatric Orphan Drugs Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Pediatric Orphan Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Pediatric Orphan Drugs Companies and Market Share, 2018-2023
        4.3.1 United States Based Pediatric Orphan Drugs Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Pediatric Orphan Drugs Revenue, (2018-2023)
    4.4 China Based Companies Pediatric Orphan Drugs Revenue and Market Share, 2018-2023
        4.4.1 China Based Pediatric Orphan Drugs Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Pediatric Orphan Drugs Revenue, (2018-2023)
    4.5 Rest of World Based Pediatric Orphan Drugs Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Pediatric Orphan Drugs Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Pediatric Orphan Drugs Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Pediatric Orphan Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Oncology Drugs
        5.2.2 Gastrointestinal Drugs
        5.2.3 Neurology Drugs
        5.2.4 Cardio-vascular Drugs
        5.2.5 Others
    5.3 Market Segment by Type
        5.3.1 World Pediatric Orphan Drugs Market Size by Type (2018-2023)
        5.3.2 World Pediatric Orphan Drugs Market Size by Type (2024-2029)
        5.3.3 World Pediatric Orphan Drugs Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Pediatric Orphan Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital Pharmacies
        6.2.2 Retail pharmacies
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Pediatric Orphan Drugs Market Size by Application (2018-2023)
        6.3.2 World Pediatric Orphan Drugs Market Size by Application (2024-2029)
        6.3.3 World Pediatric Orphan Drugs Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Recordati SpA
        7.1.1 Recordati SpA Details
        7.1.2 Recordati SpA Major Business
        7.1.3 Recordati SpA Pediatric Orphan Drugs Product and Services
        7.1.4 Recordati SpA Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Recordati SpA Recent Developments/Updates
        7.1.6 Recordati SpA Competitive Strengths & Weaknesses
    7.2 Novartis
        7.2.1 Novartis Details
        7.2.2 Novartis Major Business
        7.2.3 Novartis Pediatric Orphan Drugs Product and Services
        7.2.4 Novartis Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Novartis Recent Developments/Updates
        7.2.6 Novartis Competitive Strengths & Weaknesses
    7.3 Celgene
        7.3.1 Celgene Details
        7.3.2 Celgene Major Business
        7.3.3 Celgene Pediatric Orphan Drugs Product and Services
        7.3.4 Celgene Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Celgene Recent Developments/Updates
        7.3.6 Celgene Competitive Strengths & Weaknesses
    7.4 Abbvie
        7.4.1 Abbvie Details
        7.4.2 Abbvie Major Business
        7.4.3 Abbvie Pediatric Orphan Drugs Product and Services
        7.4.4 Abbvie Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Abbvie Recent Developments/Updates
        7.4.6 Abbvie Competitive Strengths & Weaknesses
    7.5 Orpharma
        7.5.1 Orpharma Details
        7.5.2 Orpharma Major Business
        7.5.3 Orpharma Pediatric Orphan Drugs Product and Services
        7.5.4 Orpharma Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Orpharma Recent Developments/Updates
        7.5.6 Orpharma Competitive Strengths & Weaknesses
    7.6 Amgen
        7.6.1 Amgen Details
        7.6.2 Amgen Major Business
        7.6.3 Amgen Pediatric Orphan Drugs Product and Services
        7.6.4 Amgen Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Amgen Recent Developments/Updates
        7.6.6 Amgen Competitive Strengths & Weaknesses
    7.7 Amryt Pharma Plc.
        7.7.1 Amryt Pharma Plc. Details
        7.7.2 Amryt Pharma Plc. Major Business
        7.7.3 Amryt Pharma Plc. Pediatric Orphan Drugs Product and Services
        7.7.4 Amryt Pharma Plc. Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Amryt Pharma Plc. Recent Developments/Updates
        7.7.6 Amryt Pharma Plc. Competitive Strengths & Weaknesses
    7.8 Johnson & Johnson
        7.8.1 Johnson & Johnson Details
        7.8.2 Johnson & Johnson Major Business
        7.8.3 Johnson & Johnson Pediatric Orphan Drugs Product and Services
        7.8.4 Johnson & Johnson Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Johnson & Johnson Recent Developments/Updates
        7.8.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.9 GSK
        7.9.1 GSK Details
        7.9.2 GSK Major Business
        7.9.3 GSK Pediatric Orphan Drugs Product and Services
        7.9.4 GSK Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 GSK Recent Developments/Updates
        7.9.6 GSK Competitive Strengths & Weaknesses
    7.10 Bristol-Myers Squibb Company
        7.10.1 Bristol-Myers Squibb Company Details
        7.10.2 Bristol-Myers Squibb Company Major Business
        7.10.3 Bristol-Myers Squibb Company Pediatric Orphan Drugs Product and Services
        7.10.4 Bristol-Myers Squibb Company Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Bristol-Myers Squibb Company Recent Developments/Updates
        7.10.6 Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
    7.11 Roche Holding
        7.11.1 Roche Holding Details
        7.11.2 Roche Holding Major Business
        7.11.3 Roche Holding Pediatric Orphan Drugs Product and Services
        7.11.4 Roche Holding Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Roche Holding Recent Developments/Updates
        7.11.6 Roche Holding Competitive Strengths & Weaknesses
    7.12 Pfizer
        7.12.1 Pfizer Details
        7.12.2 Pfizer Major Business
        7.12.3 Pfizer Pediatric Orphan Drugs Product and Services
        7.12.4 Pfizer Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Pfizer Recent Developments/Updates
        7.12.6 Pfizer Competitive Strengths & Weaknesses
    7.13 Sanofi
        7.13.1 Sanofi Details
        7.13.2 Sanofi Major Business
        7.13.3 Sanofi Pediatric Orphan Drugs Product and Services
        7.13.4 Sanofi Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Sanofi Recent Developments/Updates
        7.13.6 Sanofi Competitive Strengths & Weaknesses
    7.14 Takeda
        7.14.1 Takeda Details
        7.14.2 Takeda Major Business
        7.14.3 Takeda Pediatric Orphan Drugs Product and Services
        7.14.4 Takeda Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Takeda Recent Developments/Updates
        7.14.6 Takeda Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Pediatric Orphan Drugs Industry Chain
    8.2 Pediatric Orphan Drugs Upstream Analysis
    8.3 Pediatric Orphan Drugs Midstream Analysis
    8.4 Pediatric Orphan Drugs Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Pediatric Orphan Drugs Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Pediatric Orphan Drugs Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Pediatric Orphan Drugs Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Pediatric Orphan Drugs Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Pediatric Orphan Drugs Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Pediatric Orphan Drugs Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Pediatric Orphan Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Pediatric Orphan Drugs Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Pediatric Orphan Drugs Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Pediatric Orphan Drugs Players in 2022
    Table 12. World Pediatric Orphan Drugs Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Pediatric Orphan Drugs Company Evaluation Quadrant
    Table 14. Head Office of Key Pediatric Orphan Drugs Player
    Table 15. Pediatric Orphan Drugs Market: Company Product Type Footprint
    Table 16. Pediatric Orphan Drugs Market: Company Product Application Footprint
    Table 17. Pediatric Orphan Drugs Mergers & Acquisitions Activity
    Table 18. United States VS China Pediatric Orphan Drugs Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Pediatric Orphan Drugs Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Pediatric Orphan Drugs Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Pediatric Orphan Drugs Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Pediatric Orphan Drugs Revenue Market Share (2018-2023)
    Table 23. China Based Pediatric Orphan Drugs Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Pediatric Orphan Drugs Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Pediatric Orphan Drugs Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Pediatric Orphan Drugs Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Pediatric Orphan Drugs Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Pediatric Orphan Drugs Revenue Market Share (2018-2023)
    Table 29. World Pediatric Orphan Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Pediatric Orphan Drugs Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Pediatric Orphan Drugs Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Pediatric Orphan Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Pediatric Orphan Drugs Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Pediatric Orphan Drugs Market Size by Application (2024-2029) & (USD Million)
    Table 35. Recordati SpA Basic Information, Area Served and Competitors
    Table 36. Recordati SpA Major Business
    Table 37. Recordati SpA Pediatric Orphan Drugs Product and Services
    Table 38. Recordati SpA Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Recordati SpA Recent Developments/Updates
    Table 40. Recordati SpA Competitive Strengths & Weaknesses
    Table 41. Novartis Basic Information, Area Served and Competitors
    Table 42. Novartis Major Business
    Table 43. Novartis Pediatric Orphan Drugs Product and Services
    Table 44. Novartis Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Novartis Recent Developments/Updates
    Table 46. Novartis Competitive Strengths & Weaknesses
    Table 47. Celgene Basic Information, Area Served and Competitors
    Table 48. Celgene Major Business
    Table 49. Celgene Pediatric Orphan Drugs Product and Services
    Table 50. Celgene Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Celgene Recent Developments/Updates
    Table 52. Celgene Competitive Strengths & Weaknesses
    Table 53. Abbvie Basic Information, Area Served and Competitors
    Table 54. Abbvie Major Business
    Table 55. Abbvie Pediatric Orphan Drugs Product and Services
    Table 56. Abbvie Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Abbvie Recent Developments/Updates
    Table 58. Abbvie Competitive Strengths & Weaknesses
    Table 59. Orpharma Basic Information, Area Served and Competitors
    Table 60. Orpharma Major Business
    Table 61. Orpharma Pediatric Orphan Drugs Product and Services
    Table 62. Orpharma Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Orpharma Recent Developments/Updates
    Table 64. Orpharma Competitive Strengths & Weaknesses
    Table 65. Amgen Basic Information, Area Served and Competitors
    Table 66. Amgen Major Business
    Table 67. Amgen Pediatric Orphan Drugs Product and Services
    Table 68. Amgen Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Amgen Recent Developments/Updates
    Table 70. Amgen Competitive Strengths & Weaknesses
    Table 71. Amryt Pharma Plc. Basic Information, Area Served and Competitors
    Table 72. Amryt Pharma Plc. Major Business
    Table 73. Amryt Pharma Plc. Pediatric Orphan Drugs Product and Services
    Table 74. Amryt Pharma Plc. Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Amryt Pharma Plc. Recent Developments/Updates
    Table 76. Amryt Pharma Plc. Competitive Strengths & Weaknesses
    Table 77. Johnson & Johnson Basic Information, Area Served and Competitors
    Table 78. Johnson & Johnson Major Business
    Table 79. Johnson & Johnson Pediatric Orphan Drugs Product and Services
    Table 80. Johnson & Johnson Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Johnson & Johnson Recent Developments/Updates
    Table 82. Johnson & Johnson Competitive Strengths & Weaknesses
    Table 83. GSK Basic Information, Area Served and Competitors
    Table 84. GSK Major Business
    Table 85. GSK Pediatric Orphan Drugs Product and Services
    Table 86. GSK Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. GSK Recent Developments/Updates
    Table 88. GSK Competitive Strengths & Weaknesses
    Table 89. Bristol-Myers Squibb Company Basic Information, Area Served and Competitors
    Table 90. Bristol-Myers Squibb Company Major Business
    Table 91. Bristol-Myers Squibb Company Pediatric Orphan Drugs Product and Services
    Table 92. Bristol-Myers Squibb Company Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Bristol-Myers Squibb Company Recent Developments/Updates
    Table 94. Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
    Table 95. Roche Holding Basic Information, Area Served and Competitors
    Table 96. Roche Holding Major Business
    Table 97. Roche Holding Pediatric Orphan Drugs Product and Services
    Table 98. Roche Holding Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Roche Holding Recent Developments/Updates
    Table 100. Roche Holding Competitive Strengths & Weaknesses
    Table 101. Pfizer Basic Information, Area Served and Competitors
    Table 102. Pfizer Major Business
    Table 103. Pfizer Pediatric Orphan Drugs Product and Services
    Table 104. Pfizer Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Pfizer Recent Developments/Updates
    Table 106. Pfizer Competitive Strengths & Weaknesses
    Table 107. Sanofi Basic Information, Area Served and Competitors
    Table 108. Sanofi Major Business
    Table 109. Sanofi Pediatric Orphan Drugs Product and Services
    Table 110. Sanofi Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Sanofi Recent Developments/Updates
    Table 112. Takeda Basic Information, Area Served and Competitors
    Table 113. Takeda Major Business
    Table 114. Takeda Pediatric Orphan Drugs Product and Services
    Table 115. Takeda Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 116. Global Key Players of Pediatric Orphan Drugs Upstream (Raw Materials)
    Table 117. Pediatric Orphan Drugs Typical Customers
List of Figure
    Figure 1. Pediatric Orphan Drugs Picture
    Figure 2. World Pediatric Orphan Drugs Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Pediatric Orphan Drugs Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Pediatric Orphan Drugs Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Pediatric Orphan Drugs Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Pediatric Orphan Drugs Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Pediatric Orphan Drugs Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Pediatric Orphan Drugs Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Pediatric Orphan Drugs Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Pediatric Orphan Drugs Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Pediatric Orphan Drugs Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Pediatric Orphan Drugs Revenue (2018-2029) & (USD Million)
    Figure 13. Pediatric Orphan Drugs Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Pediatric Orphan Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Pediatric Orphan Drugs by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Pediatric Orphan Drugs Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Pediatric Orphan Drugs Markets in 2022
    Figure 27. United States VS China: Pediatric Orphan Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Pediatric Orphan Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Pediatric Orphan Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Pediatric Orphan Drugs Market Size Market Share by Type in 2022
    Figure 31. Oncology Drugs
    Figure 32. Gastrointestinal Drugs
    Figure 33. Neurology Drugs
    Figure 34. Cardio-vascular Drugs
    Figure 35. Others
    Figure 36. World Pediatric Orphan Drugs Market Size Market Share by Type (2018-2029)
    Figure 37. World Pediatric Orphan Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 38. World Pediatric Orphan Drugs Market Size Market Share by Application in 2022
    Figure 39. Hospital Pharmacies
    Figure 40. Retail pharmacies
    Figure 41. Others
    Figure 42. Pediatric Orphan Drugs Industrial Chain
    Figure 43. Methodology
    Figure 44. Research Process and Data Source

Companies Mentioned

Recordati SpA
Novartis
Celgene
Abbvie
Orpharma
Amgen
Amryt Pharma Plc.
Johnson & Johnson
GSK
Bristol-Myers Squibb Company
Roche Holding
Pfizer
Sanofi
Takeda